Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Barclays analyst Eliana Merle maintains Madrigal Pharmaceuticals with a Overweight and lowers the price target from $964 to $962.